Study evaluated analgesic activity of enantiomeric prenylated neolignans in zebrafish and mice, suggesting potential therapeutic applications.
Two pairs of unprecedented enantiomeric prenylated neolignans (1a/1b and 2a/2b) with an unparalleled 9.2′,8.O.3′-linked skeleton were isolated from the roots of Illicium verum, along with three biogenetically related metabolites (3a/3b and 4). The structures of these compounds were elucidated using spectroscopic techniques, X-ray crystallography analysis, and quantum chemical calculations. Both 2,4,5-trioxygenated phenylpropanoids (represented by 4) and their analogues with dearomatization of the benzene ring (represented by 3) are uncommon. Compounds 1a/1b and 2a/2b are likely produced by their dimerization. Inspired by the traditional effects of I. verum’s fruits, the analgesic activities of compounds 1–4 were evaluated using a glacial acetic acid-induced zebrafish pain model. The results indicated that all compounds showed different levels of analgesic activity. A major and active prenylated 2,4,5-trioxygenated phenylpropanoid with the dearomatization of the benzene ring (3) exhibited dose-dependent analgesic activity in a formalin-induced mouse paw licking assay. The analgesic potency of compound 3 is comparable to that of the positive drug diclofenac sodium (DCS) under the same dose (10 mg/kg). The analgesic potencies of compounds 3, 3a, and 3b were also comparable under a 2 mg/kg dose. The analgesic activities of prenylated phenylpropanoids with dearomatization of the benzene ring are first reported herein.
No takes yet. Share an insight, caveat, or question.
Zou et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: